Jamie Shaw

Phase 1 study in healthy participants of the safety, pharmacokinetics, and pharmacodynamics of enpatoran (M5049), a dual antagonist of toll‐like receptors 7 and 8

Andreas Port, Jamie Shaw, Lena Klopp‐Schulze et al. · Pharmacology Research & Perspectives · 2021 · 44 citations · Full text

The Use of Sentinel Lymph Node Biopsy in Ductal Carcinoma in Situ

Christopher Schneider, Steven D. Trocha, Brian McKinley et al. · The American Surgeon · 2010 · 29 citations

Phase 1 study of M2698, a p70S6K/AKT dual inhibitor, in patients with advanced cancer

Apostolia M. Tsimberidou, Jamie Shaw, Dejan Juric et al. · Journal of Hematology & Oncology · 2021 · 28 citations · Full text

AKT inhibition in the central nervous system induces signaling defects resulting in psychiatric symptomatology

Apostolia M. Tsimberidou, Antonis Skliris, Alan Valentine et al. · Cell & Bioscience · 2022 · 21 citations · Full text

Asia‐Inclusive Global Development of Enpatoran: Results of an Ethno‐Bridging Study, Intrinsic/Extrinsic Factor Assessments and Disease Trajectory Modeling to Inform Design of a Phase II Multiregional Clinical Trial

Lena Klopp‐Schulze, Sathej Gopalakrishnan, Özkan Yalkinoglu et al. · Clinical Pharmacology & Therapeutics · 2024 · 16 citations · Full text